key: cord-0849009-tkh93k1u authors: Zhao, Qianwen; Meng, Meng; Kumar, Rahul; Wu, Yinlian; Huang, Jiaofeng; Lian, Ningfang; Deng, Yunlei; Lin, Su title: The impact of COPD and smoking history on the severity of COVID‐19: A systemic review and meta‐analysis date: 2020-05-17 journal: J Med Virol DOI: 10.1002/jmv.25889 sha: 767f4e7cb2d23b17174e3f0638b75a49043fe321 doc_id: 849009 cord_uid: tkh93k1u Comorbidities are associated with the severity of coronavirus disease 2019 (COVID‐19). This meta‐analysis aimed to explore the risk of severe COVID‐19 in patients with pre‐existing chronic obstructive pulmonary disease (COPD) and ongoing smoking history. A comprehensive systematic literature search was carried out to find studies published from December 2019 to 22 March 2020 from five databases. The languages of literature included English and Chinese. The point prevalence of severe COVID‐19 in patients with pre‐existing COPD and those with ongoing smoking was evaluated with this meta‐analysis. Overall 11 case series, published either in Chinese or English language with a total of 2002 cases, were included in this study. The pooled OR of COPD and the development of severe COVID‐19 was 4.38 (fixed‐effects model; 95% CI: 2.34‐8.20), while the OR of ongoing smoking was 1.98 (fixed‐effects model; 95% CI: 1.29‐3.05). There was no publication bias as examined by the funnel plot and Egger's test (P = not significant). The heterogeneity of included studies was moderate for both COPD and ongoing smoking history on the severity of COVID‐19. COPD and ongoing smoking history attribute to the worse progression and outcome of COVID‐19. endpoints appropriate to the aim of the study, unbiased assessment of the study endpoint, follow-up period appropriate to the aim of the study, loss to follow up less than 5%, and prospective calculation of the study size. The items were scored "0" if it was not reported, "1" if it was reported but inadequate, "2" if reported and adequate. Data extraction and the evaluation of literature quality were conducted independently by two investigators (MM and QZ). Microsoft Excel database was created to record the available information including baseline details and the rate of development of severe COVID-19 in patients with different respiratory conditions. Any disagreement was resolved by another investigator (SL). Microsoft Excel was used to analyze the clinical symptoms and laboratory results. Meta-analysis was carried out using R-software (version 3.6.3, available on https://www.r-project.org). Heterogeneity among studies was tested using the Cochran χ 2 test and I 2 . When I 2 was less than 50%, a fixed-effects model was used, and when I 2 was more than 50%, a random-effects model was used. Sensitivity analysis was conducted to determine the source of heterogeneity by excluding one study at a time. After excluding significant clinical heterogeneity, the random-effects model was used for meta-analysis. Funnel plot and Egger test were used to detect any publication bias. A P value of less than 0.05 was considered statistically significant. On the basis of predefined search strategy, a total of 2472 studies were found in the five online databases as described above. After removing the duplicate records, 1596 articles were obtained. Besides, another 1544 articles were excluded as they were not relevant to current meta-analysis. Full texts of the remaining 48 articles were then assessed for eligibility, 37 of which were removed for various reasons. Eventually 11 articles (1 in Chinese and 10 in English) 6, [8] [9] [10] [11] [12] [13] [14] [15] [16] were included in the analysis ( Figure 1 ). The patient characteristics and demographic data of the included studies are shown in Table 1 . All the reported and thus included studies were case series, sample size calculation was not relevant. The follow-up period was either not or inadequately reported in most studies. The overall quality of available literature was moderate with MINORS scores ranging from 10 to 13. The quality of the included articles is evaluated and shown in Table S1 . Figure 2D ). As the reported endpoints varied between including literatures, a subgroup analysis was performed to find out the impact of different endpoints on the effect of COPD or smoking on COVID-19. As shown in Figure 3A , pre-existing COPD is significantly associated with me- However, in the subgroup analysis, this effect was no longer significant in either subgroup. The weight of a single study on the From SARS to COVID-19: a previously unknown SARS-related coronavirus (SARS-CoV-2) of pandemic potential infecting humans-call for a one health approach. One Health Coronavirus disease 2019: what we know WHO coronavirus disease situation reports The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients Imaging and clinical features of patients with 2019 novel coronavirus SAR-CoV-2: a systematic review and meta-analysis Clinical characteristics of coronavirus disease 2019 in China Active smoking is not associated with severity of coronavirus disease 2019 (COVID-19) Clinical features of patients infected with 2019 novel coronavirus in Wuhan Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy Clinical features of 69 cases with coronavirus disease Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19 Retrospective study on the epidemiological characteristics of 139 patients with novel coronavirus pneumonia on the effects of severity Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease Cellular and structural bases of chronic obstructive pulmonary disease The role of acute and chronic respiratory colonization and infections in the pathogenesis of COPD